rs1553396458
Variant summary
Our verdict is Pathogenic. The variant received 15 ACMG points: 15P and 0B. PM2PM5PP2PP3_ModeratePP5_Very_Strong
The NM_001615.4(ACTG2):c.632G>A(p.Arg211Gln) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000139 in 1,440,226 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R211L) has been classified as Pathogenic.
Frequency
Consequence
NM_001615.4 missense
Scores
Clinical Significance
Conservation
Publications
- visceral myopathy 1Inheritance: AR, AD Classification: STRONG, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
- familial visceral myopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- megacystis-microcolon-intestinal hypoperistalsis syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 15 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| ACTG2 | ENST00000345517.8 | c.632G>A | p.Arg211Gln | missense_variant | Exon 7 of 9 | 1 | NM_001615.4 | ENSP00000295137.3 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD4 exome AF: 0.00000139 AC: 2AN: 1440226Hom.: 0 Cov.: 31 AF XY: 0.00000140 AC XY: 1AN XY: 715836 show subpopulations ⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
Age Distribution
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
Visceral myopathy 1 Pathogenic:2Other:1
Insufficient data for genotype-phenotype correlations -
- -
Identified as a de novo event in our clinical cohort of MMIHS -
not provided Pathogenic:1
Identified in two individuals from the same family with CIPO or MMIHS (PMID: 29387497); Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 29387497) -
ACTG2-related disorder Uncertain:1
The ACTG2 c.632G>A variant is predicted to result in the amino acid substitution p.Arg211Gln. This variant was reported in an individual with megacystis microcolon intestinal hypoperistalsis syndrome (MMIHS) (Table S2 and S3, ID FAM53-1 or Fam53, maternally-inherited, Assia Batzir et al. 2019. PubMed ID: 31769566) and was also reported in an individual with chronic intestinal pseudoobstruction and in her fetus with MMIHS (Whittington et al. 2017. PubMed ID: 29387497). This variant has not been reported in a large population database, indicating this variant is rare. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at